SCHEMBL24310557

SCHEMBL24310557

Cc1cccc(C)c1-c1cc(Oc2ccc(CC=O)cc2)nc(NSc2cnn(C)c2)n1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DGAT2 Q96PD7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310347 0.87 GPR39 (0.39) —
SCHEMBL24310563 0.87 HPGD (0.31) —
SCHEMBL24310060 0.86 HTR7 (0.33) —
SCHEMBL24310126 0.85 AURKA (0.36) —
SCHEMBL24310142 0.85 GPR39 (0.30) —
SCHEMBL24309561 0.85 KMT2A (0.31) —
SCHEMBL24310202 0.84 PLK4 (0.38) —
SCHEMBL24309553 0.83 MAP4K1 (0.31) —
SCHEMBL24310587 0.83 FLT3 (0.37) —
SCHEMBL24309575 0.82 NPC1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback